HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer United States

In Brief

This article was originally published in The Rose Sheet

  • News

Executive Summary

J&J’s McNeil-PPC Inc unit has sold its Reach toothbrush brand to Dr Fresh, LLC for an undisclosed sum; Laura Geller makes deal to drive its expansion. More news in brief.

You may also be interested in...



NPA On The Hill, Recalls: Health And Wellness New Products Roundup

Natural Products Day marks 20 years; Plandai helm stays in Duffield family; diaper rash cream, high-lead supplements recalled; and more news in brief.

High Ridge Brands Follows Expansion Overtures With Dr. Fresh Buy

Dr. Fresh changes private equity owner hands with the announced acquisition, which adds REACH and Firefly toothbrushes and other oral-care products to High Ridge’s growing personal-care portfolio.

Portfolio Firm Glansaol Looks To Make Mark In Prestige, Led By Ex-Revlon CEO

More deals may be on the horizon for portfolio company Glansaol following its announced market entry with the acquisition of three prestige brands.

Table

View full table

Topics

Related Companies

Tags:
Consumer United States
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS018419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By